Showing results (61-70 of 88) with videos related to
Sort By:
Pageof 9
Journal of Affective Disorders|October 27, 2015
Asenapine: Efficacy and safety of 5 and 10mg bid in a 3-week, randomized, double-blind, placebo-controlled trial in adults with a manic or mixed episode associated with bipolar I disorderRonald L Landbloom, Mary Mackle, Xiao Wu, et al.Journal of Child and Adolescent Psychopharmacology|June 20, 2015
Safety and Efficacy from an 8 Week Double-Blind Trial and a 26 Week Open-Label Extension of Asenapine in Adolescents with SchizophreniaRobert L Findling, Ronald P Landbloom, Mary Mackle, et al.CNS Drugs|January 28, 2021
Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An OverviewChristoph U Correll, Edward Kim, Jennifer Kern Sliwa, et al.Journal of Medical Economics|January 20, 2022
Patient profiles, initial hospital encounter characteristics, and hospital re-encounters of patients with a hospital emergency department visit or inpatient admission for major depressive disorderQiaoyi Zhang, Marguerite O'Hara, Carter McCormick, et al.Neuropsychiatric Disease and Treatment|July 2, 2020
Comparison of Relapse Prevention with 3 Different Paliperidone Formulations in Patients with Schizophrenia Continuing versus Discontinuing Active Antipsychotic Treatment: A Post-Hoc Analysis of 3 Similarly Designed Randomized StudiesMaju Mathews, Srihari Gopal, Arun Singh, et al.Neuropsychiatric Disease and Treatment|June 14, 2019
Clinical relevance of paliperidone palmitate 3-monthly in treating schizophreniaMaju Mathews, Srihari Gopal, Isaac Nuamah, et al.Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2015
Asenapine for the Acute Treatment of Pediatric Manic or Mixed Episode of Bipolar I DisorderRobert L Findling, Ronald L Landbloom, Armin Szegedi, et al.Pain Practice : the Official Journal of World Institute of Pain|March 5, 2011
Retrospective review of 707 cases of spinal cord stimulation: indications and complicationsNagy A Mekhail, Manu Mathews, Fady Nageeb, et al.Patient Preference and Adherence|October 11, 2021
Relapse and Treatment Adherence in Patients with Schizophrenia Switching from Paliperidone Palmitate Once-Monthly to Three-Monthly Formulation: A Retrospective Health Claims Database AnalysisGang Li, Alexander Keenan, Mehmet Daskiran, et al.BMC Psychiatry|August 11, 2023
Esketamine versus placebo on time to remission in major depressive disorder with acute suicidalityDong-Jing Fu, Qiaoyi Zhang, Ling Shi, et al.Pageof 9